Catatonia associated with initiating paliperidone treatment.

Abstract

We present a case of catatonia, which occurred shortly after starting a new antipsychotic, paliperidone, an active metabolite of risperidone. Catatonia may be caused by a variety of conditions, including metabolic, neurologic, psychiatric and toxic processes. Interestingly, risperidone, which has been thought to cause several cases of catatonia, has also been recommended as a potential treatment. We discuss potential mechanisms for causes of drug-induced catatonia as well as potential treatment options.

• Authors: Nathanael J McKeown, James H Bryan, B Zane Horowitz
• Journal: The western journal of emergency medicine (West J Emerg Med) Vol. 11 Issue 2 Pg. 186-8 (May 2010) ISSN: 1936-9018 [Electronic] United States
• PMID: 20823970 (Publication Type: Journal Article)